U.S. Animal Biotechnology Market, 2025-2030
The animal biotechnology market in the United States is expected to reach a projected revenue of US$ 12,858.8 million by 2030. A compound annual growth rate of 10.6% is expected of the United States animal biotechnology market from 2025 to 2030.
Revenue, 2024 (US$M)
$7,073.8
Forecast, 2030 (US$M)
$12,858.8
CAGR, 2025 - 2030
10.6%
Report Coverage
U.S.
Global Market
Related Markets
U.S. animal biotechnology market highlights
- The U.S. animal biotechnology market generated a revenue of USD 7,073.8 million in 2024 and is expected to reach USD 12,858.8 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.6% from 2025 to 2030.
- In terms of segment, biologics was the largest revenue generating product in 2024.
- Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
Animal biotechnology market data book summary
| Market revenue in 2024 | USD 7,073.8 million |
| Market revenue in 2030 | USD 12,858.8 million |
| Growth rate | 10.6% (CAGR from 2025 to 2030) |
| Largest segment | Biologics |
| Fastest growing segment | Biologics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Biologics, Drugs, Reproductive And Genetic, Nutrition |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Biogenesis Bago, Merck & Co Inc, Virbac SA, Elanco Animal Health Inc, IDEXX Laboratories Inc, HESKA, Indian Immunologicals, Hester Biosciences, Kareo, NXGN |
Other key industry trends
- In terms of revenue, U.S. accounted for 25.2% of the global animal biotechnology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. animal biotechnology market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 12,858.8 million by 2030.
No credit card required*
Publish Date: Dec 09, 2024
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Animal Biotechnology Market Report
Animal biotechnology market report segmentation & scope
Others
Animal Biotechnology Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Virbac SA | View profile | 5,400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | www.virbac.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Elanco Animal Health Inc | View profile | 9,800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | www.elanco.com |
| IDEXX Laboratories Inc | View profile | 11,000 | One IDEXX Drive, Westbrook, ME, United States, 04092 | www.idexx.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Indian Immunologicals | View profile | 1001-5000 | Hyderabad, Andhra Pradesh, India, Asia | indimmune.com |
| NXGN | View profile | 11-50 | Chicago, Illinois, United States, North America | nxgn.io/ |
| Kareo | View profile | 501-1000 | Irvine, California, United States, North America | www.kareo.com |
| Biogenesis Bago | View profile | 501-1000 | Garín, Buenos Aires, Argentina, South America | www.biogenesisbago.com/en/ |
U.S. animal biotechnology market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Animal Biotechnology Market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 34.91% in 2024.
Horizon Databook has segmented the U.S. animal biotechnology market based on diagnostics, biologics, drugs, reproductive and genetic, nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Animal Biotechnology Market Product Outlook (Revenue, USD Million , 2018-2030)
- Diagnostics
- Biologics
- Drugs
- Reproductive And Genetic
- Nutrition
- U.S. Animal Biotechnology Market Application Outlook (Revenue, USD Million , 2018-2030)
- Diagnosis of Animal Diseases
- Treatment of Animal Diseases
- Preventive Care of Animals
- Product Research & Development
- Others
- U.S. Animal Biotechnology Market Animal Type Outlook (Revenue, USD Million , 2018-2030)
- Companion
- Livestock
- U.S. Animal Biotechnology Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Laboratories
- Point-of-care testing/In-house testing
- Veterinary Hospitals & Clinics
- Others
Reasons to subscribe to animal biotechnology market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of animal biotechnology market report databook
- Our clientele includes a mix of animal biotechnology market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. animal biotechnology market report, including forecasts for subscribers. This country databook contains high-level insights into U.S. animal biotechnology market report from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.S. Animal Biotechnology Market, 2018-2030 (US$M)
U.S. animal biotechnology market statistics, by product, 2018-2030 (US$M)
